Immune Checkpoint Inhibitor-induced Uveitis: Disproportionality and Timing Analyses of the Japanese Pharmacovigilance Database
Anticancer Research · 2025
DOI: 10.21873/anticanres.17595 ↗Kurz gefasst
Fachartikel in der Zeitschrift Anticancer Research, 2025. Verfasst von Naohito Ide und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Practical Pharmacy, Nihon Pharmaceutical University, Saitama, Japan; n-ide@nichiyaku.ac.jp. Hauptthemen laut MEDLINE: Immune Checkpoint Inhibitors, Uveitis, Neoplasms. Die Arbeit wurde bisher 1-mal zitiert (Crossref).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Practical Pharmacy, Nihon Pharmaceutical University, Saitama, Japan; n-ide@nichiyaku.ac.jp.
- Department of Clinical Pharmacology, Nihon Pharmaceutical University, Saitama, Japan.
Zitieren
APA
Ide, N., Sako, K. I., & Maeda, T. (2025). Immune Checkpoint Inhibitor-induced Uveitis: Disproportionality and Timing Analyses of the Japanese Pharmacovigilance Database. Anticancer Research. https://doi.org/10.21873/anticanres.17595
Vancouver
Ide N, Sako KI, Maeda T. Immune Checkpoint Inhibitor-induced Uveitis: Disproportionality and Timing Analyses of the Japanese Pharmacovigilance Database. Anticancer Research. 2025. doi:10.21873/anticanres.17595
BibTeX
@article{Ide2025,
author = {Ide, Naohito and Sako, Ken-Ichi and Maeda, Tomoji},
title = {Immune Checkpoint Inhibitor-induced Uveitis: Disproportionality and Timing Analyses of the Japanese Pharmacovigilance Database},
journal = {Anticancer Research},
year = {2025},
doi = {10.21873/anticanres.17595}
}
EUVIMED